Search research articles
Contact Us
Filters
Showing results (31-40 of 120) with videos related to
Page
of 12
Sort By:
Zhonghua Nei Ke Za Zhi
|
August 8, 2008
[Bortezomib-based combination therapy for newly diagnosed multiple myeloma]
Li Bao, Xi-jin Lu, Xiao-hui Zhang, et al.
Leukemia Research
|
September 22, 2017
The kinetics of white blood cell and the predictive factors of leukocytosis under oral or intravenous arsenic as the first-line treatment for acute promyelocytic leukemia
Fang Wang, Jin-Song Jia, Jing Wang, et al.
Journal of Clinical Apheresis
|
April 26, 2012
Dynamics of monocyte count: a good predictor for timing of peripheral blood stem cell collection
Shen-Miao Yang, Huan Chen, Yu-Hong Chen, et al.
Critical Reviews in Oncology/Hematology
|
January 22, 2019
Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis
Xiaotong Yu, Liping Liu, Zhenwei Xie, et al.
Cellular and Molecular Life Sciences : CMLS
|
May 27, 2022
PRMT5-mediated RNF4 methylation promotes therapeutic resistance of APL cells to As<sub>2</sub>O<sub>3</sub> by stabilizing oncoprotein PML-RARα
Xinping Huang, Yongfeng Yang, Dan Zhu, et al.
Cancer
|
March 7, 2023
Chemotherapy with the use of next-generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
Mixue Xie, Ting Shi, Qi Jiang, et al.
Biochemical and Biophysical Research Communications
|
March 3, 2019
Identification of a point mutation PML<sup>S214L</sup>-RARα that alters PML body organization, dynamics and SUMOylation
Shanshan Zhao, Peng Shi, Qihang Zhong, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
July 8, 2003
[Specific anti-leukemic cell effect mediated by dendritic cells pulsed with chronic myelogenous leukemia lysate antigen in vitro]
Hong-Hu Zhu, Kai-Lin Xu, Xiu-Ying Pan, et al.
Leukemia Research
|
September 26, 2015
Reduced medical costs and hospital days when using oral arsenic plus ATRA as the first-line treatment of acute promyelocytic leukemia
Hao Jiang, Gong-Wen Liang, Xiao-Jun Huang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
May 17, 2011
[Effect of different regimens on bone disease of multiple myeloma]
Li Bao, Xi-jing Lu, Xiao-hui Zhang, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 120) with videos related to
Sort By:
Page
of 12
Zhonghua Nei Ke Za Zhi
|
August 8, 2008
[Bortezomib-based combination therapy for newly diagnosed multiple myeloma]
Li Bao, Xi-jin Lu, Xiao-hui Zhang, et al.
Leukemia Research
|
September 22, 2017
The kinetics of white blood cell and the predictive factors of leukocytosis under oral or intravenous arsenic as the first-line treatment for acute promyelocytic leukemia
Fang Wang, Jin-Song Jia, Jing Wang, et al.
Journal of Clinical Apheresis
|
April 26, 2012
Dynamics of monocyte count: a good predictor for timing of peripheral blood stem cell collection
Shen-Miao Yang, Huan Chen, Yu-Hong Chen, et al.
Critical Reviews in Oncology/Hematology
|
January 22, 2019
Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis
Xiaotong Yu, Liping Liu, Zhenwei Xie, et al.
Cellular and Molecular Life Sciences : CMLS
|
May 27, 2022
PRMT5-mediated RNF4 methylation promotes therapeutic resistance of APL cells to As<sub>2</sub>O<sub>3</sub> by stabilizing oncoprotein PML-RARα
Xinping Huang, Yongfeng Yang, Dan Zhu, et al.
Cancer
|
March 7, 2023
Chemotherapy with the use of next-generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
Mixue Xie, Ting Shi, Qi Jiang, et al.
Biochemical and Biophysical Research Communications
|
March 3, 2019
Identification of a point mutation PML<sup>S214L</sup>-RARα that alters PML body organization, dynamics and SUMOylation
Shanshan Zhao, Peng Shi, Qihang Zhong, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
July 8, 2003
[Specific anti-leukemic cell effect mediated by dendritic cells pulsed with chronic myelogenous leukemia lysate antigen in vitro]
Hong-Hu Zhu, Kai-Lin Xu, Xiu-Ying Pan, et al.
Leukemia Research
|
September 26, 2015
Reduced medical costs and hospital days when using oral arsenic plus ATRA as the first-line treatment of acute promyelocytic leukemia
Hao Jiang, Gong-Wen Liang, Xiao-Jun Huang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
May 17, 2011
[Effect of different regimens on bone disease of multiple myeloma]
Li Bao, Xi-jing Lu, Xiao-hui Zhang, et al.
Page
of 12